VANGUARD GROUP INC 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:30 am Sale | 2022-12-30 | 13G | Ovid Therapeutics Inc. OVID | VANGUARD GROUP INC | 2,581,736 3.660% | -860,882 (-25.01%) | Filing |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | Ovid Therapeutics Inc. OVID | VANGUARD GROUP INC | 3,442,618 5.060% | 3,442,618 (New Position) | Filing |